Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
Stephen J. Schuster, Constantine S. Tam, Peter Borchmann, Nina Worel, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael R. Bishop, Lloyd E. Damon, Stephen Ronan Foley, Jason R. Westin, Isabelle Fleury, P. Joy Ho, Stephan Mielke, Takanori Teshima, Murali Janakiram, Jing Mei Hsu, Koji Izutsu, Marie José KerstenMonalisa Ghosh, Nina Wagner-Johnston, Koji Kato, Paolo Corradini, Marcela Martinez-Prieto, Xia Han, Ranjan Tiwari, Gilles Salles, Richard T. Maziarz
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study'. Together they form a unique fingerprint.